Orthofix Benefits from New Products to Offset COVID Impact

Orthofix's logo

Orthofix reported 2Q21 orthopedic revenue of $121.4 million, +66% vs. 2Q20. Compared to the second quarter of 2019, revenue grew by +4.8%. Orthofix increased its full-year 2021 guidance to the range of $468 million to $474 million, representing growth in the range of +1.7% to +3.1% compared to 2019.

The company benefitted from new products...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us